Farzin Khosrow-Khavar, PhD

Instructor
Rutgers University, United States

Farzin Khosrow-Khavar PhD is an Instructor of Epidemiogy at Rutgers Center for Pharmacoepidemiology and Treatment Science and Rutgers School of Public Health, and a member of Rutgers Cancer Institute. He is a cancer epidemiologist and pharmacoepidemiologist with an overarching goal of combining advanced study designs and methods with large electronic health records to generate evidence that informs the equitable, effective, and safe use of cancer treatments in clinical practice. His current research focus is on utilization, comparative effectiveness, and safety of novel treatments in hormone-sensitive malignancies.

Disclosure information not submitted.

Presentation(s):

• Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated With JAK inhibitors and TNF inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study

  Monday, August 26, 2024
  2:45 PM – 3:00 PM CEST

• The Comparative Risk of Urinary Tract Infections with Degarelix and Gonadotropin-Releasing Hormone Agonists among Patients Diagnosed with Prostate Cancer: A Population-Based Cohort Study

  Tuesday, August 27, 2024
  1:30 PM – 1:45 PM CEST

• Racial, Ethnic, and Socioeconomic Disparities in P2Y12 Inhibitor Prescribing Following PCI in Medicare Beneficiaries

  Wednesday, August 28, 2024
  9:45 AM – 10:00 AM CEST